Literature DB >> 10590303

Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells.

M Dathe1, T Wieprecht.   

Abstract

Antibacterial, membrane-lytic peptides belong to the innate immune system and host defense mechanism of a multitude of animals and plants. The largest group of peptide antibiotics comprises peptides which fold into an amphipathic alpha-helical conformation when interacting with the target. The activity of these peptides is thought to be determined by global structural parameters rather than by the specific amino acid sequence. This review is concerned with the influence of structural parameters, such as peptide helicity, hydrophobicity, hydrophobic moment, peptide charge and the size of the hydrophobic/hydrophilic domain, on membrane activity and selectivity. The potential of these parameters to increase the antibacterial activity and to improve the prokaryotic selectivity of natural and model peptides is assessed. Furthermore, biophysical studies are summarized which elucidated the molecular basis for activity and selectivity modulations on the level of model membranes. Finally, the knowledge about the role of peptide structural parameters is applied to understand the different activity spectra of natural membrane-lytic peptides.

Mesh:

Substances:

Year:  1999        PMID: 10590303     DOI: 10.1016/s0005-2736(99)00201-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  158 in total

1.  N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide.

Authors:  C Chicharro; C Granata; R Lozano; D Andreu; L Rivas
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  Diffusion as a probe of the heterogeneity of antimicrobial peptide-membrane interactions.

Authors:  Kathryn B Smith-Dupont; Lin Guo; Feng Gai
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

3.  Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study.

Authors:  Kalpana Bhargava; Jimmy B Feix
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

4.  Inner field compensation as a tool for the characterization of asymmetric membranes and Peptide-membrane interactions.

Authors:  Sven O Hagge; Andre Wiese; Ulrich Seydel; Thomas Gutsmann
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

Review 5.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Membrane perturbation induced by interfacially adsorbed peptides.

Authors:  Assaf Zemel; Avinoam Ben-Shaul; Sylvio May
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

7.  Infrared reflection absorption spectroscopy of amphipathic model peptides at the air/water interface.

Authors:  Andreas Kerth; Andreas Erbe; Margitta Dathe; Alfred Blume
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

8.  The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.

Authors:  Mercedeh Tajbakhsh; Abdollah Karimi; Abolghasem Tohidpour; Naser Abbasi; Fatemeh Fallah; Maziar Mohammad Akhavan
Journal:  J Microbiol       Date:  2018-02-02       Impact factor: 3.422

9.  Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.

Authors:  Joanna Koziel; Danuta Bryzek; Aneta Sroka; Katarzyna Maresz; Izabela Glowczyk; Ewa Bielecka; Tomasz Kantyka; Krzysztof Pyrć; Pavel Svoboda; Jan Pohl; Jan Potempa
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

10.  The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives.

Authors:  Kenichi Kuroda; Gregory A Caputo; William F DeGrado
Journal:  Chemistry       Date:  2009       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.